Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0268318 (
ICP
)
10,007
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In cells infected with herpes simplex virus, HSV-I, newly synthesized polypeptides accumulated in the nucleus at different rates, which did not change during the first 6 h after infection.
Canavanine
, an arginine analogue, prevented the nuclear accumulation of
ICP
(infected cell polypeptides) 5 and 8 and azetidine, a proline analogue, prevented that of
ICP
5 and 7. The transfer of polypeptides to the nucleus was inhibited at 4 degrees C but not by dinitrophenol. Some of the nuclear polypeptides could be released by washing isolated nuclei with hypertonic salt solutions.
ICP
17 was particularly sensitive to high salt treatment while
ICP
5 and II were resistent.
ICP
4b, a modified form of the alpha polypeptide
ICP
4, was released by EDTA, and the detergent NP40 removed
ICP
II. Treatment of nuclei with DNase selectively reduced the amount of bound alpha polypeptides
ICP
4c (the second modified form of
ICP
4), 0 and 27 as well as
ICP
8 and 25. Nuclei isolated from infected or uninfected cells and incubated in labelled cytoplasmic extracts took up primarily
ICP
8 and 32. Alpha polypeptides were taken up to a lesser extent and
ICP
6 and 10 were excluded. It is concluded that affinities for various constituents of host cell nuclei are likely to determine the nuclear accumulation of specific virus polypeptides.
...
PMID:On the association of virus proteins with the nuclei of cells infected with herpes simplex virus. 20 19